Other languages Axonics, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 11:11:19 2024-04-29 EDT			5-day change	1st Jan Change
66.78 ^USD	+0.13%		-0.19%	+7.21%

04-04	Boston Scientific, Axonics Receive FTC Second Request on Merger Deal	MT
04-04	Boston Scientific, Axonics Merger Prompts FTC to Request Additional Information	DJ

MÄRKTE USA/Börsen deutlich im Minus - Warten auf US-Arbeitsmarktbericht	04-04
MÄRKTE USA/Wall Street mit Aufschlägen	04-04
Boston Scientific, Axonics Receive FTC Second Request on Merger Deal	04-04
MÄRKTE USA/Fester - Warten auf US-Arbeitsmarktbericht	04-04
MÄRKTE USA/Etwas fester - Warten auf Arbeitsmarktbericht	04-04
FTC seeks additional information for Boston Scientific's $3.7 bln Axonics deal	04-04
Medtronic to Ask Court to Resume Patent Infringement Case Against Axonics After Favorable Patent Office Ruling	03-21
Axonics to Sell Rechargeable Sacral Neuromodulation System in Europe Starting April	03-14
Axonics Q4 Earnings, Revenue Rise -- Shares Edge Higher After Hours	02-28
Axonics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-28
Boston Scientific Prices $2.17 Billion Euro-Denominated Notes Offering	02-23
Axonics Insider Sold Shares Worth $2,381,662, According to a Recent SEC Filing	02-02
Axonics Insider Sold Shares Worth $1,125,432, According to a Recent SEC Filing	02-02
Axonics Insider Sold Shares Worth $1,103,961, According to a Recent SEC Filing	01-11
Sector Update: Health Care Stocks Rise Late Afternoon	01-08
Sector Update: Health Care Stocks Rise in Afternoon Trading	01-08
Sector Update: Health Care	01-08
Boston Scientific Signs $3.7 Billion Deal to Buy Medical Technology Company Axonics	01-08
Drugmakers kick off industry conference with two cancer deals	01-08
Axonics Sees Higher Q4, Fiscal 2023 Revenue	01-08

No results for this search